September 22, 2016—Republicans and Democrats on the House Oversight Committee yesterday ripped Mylan chief executive Heather Bresch during a hearing about the outrageously high price of Mylan’s EpiPen anaphylaxis rescue injectors.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)